Urol. praxi. 2018;19(1):42-45
Bladder mucosa regeneration after chronic inflammations
- Urologické oddělení, Slezská nemocnice v Opavě
The urinary tract is the second most often location of infections in the human body. Repeated and inappropriately treatedinfections cause weakening of bladder mucosa, which has relatively restricted means of regeneration. As a result of long-timedamaging of the epithelium, revealing and irritating of nerve endings inside the bladder wall with consequent difficulties occur.Those complaints are best characterised in a hard to catch modality called interstitial cystitis. It is an illness summarised as PainfulBladder Syndrome causing lingering troubles to patients on one hand side, on the other hand putting the physician in a difficultposition in the question of treatment that often does not lead to the desired healing.
Keywords: mucosa regeneration, chronic inflammation, painful bladder syndrome, therapy
Published: March 15, 2018 Show citation
References
- Kladenský J. Infekce močových cest a diabetes mellitus. Urol. praxi, 2013; 14(2): 56-58. Dostupný z: https://www.urologiepropraxi.cz/pdfs/uro/2013/02/03.pdf
- Hanuš T. Intersticiální cystitida. Praha: Nucleus HK 2002: 6.
- Kawaciuk I. Urologie. Praha: Galén 2009: 229-233.
- Staněk R. Infekce močových cest II - speciální část. Urol. praxi, 2010, 11(1): 41-44. Dostupný z: https://www.urologiepropraxi.cz/pdfs/uro/2010/01/10.pdf
- Štefan M. Léčba infekcí močových cest v éře antibiotické rezistence. Urol. praxi, 2017; 18(1): 17-20. Dostupný z: https://www.urologiepropraxi.cz/pdfs/uro/2017/01/05.pdf
Go to original source... - Netušený význam střevního mikrobiálního ekosystému. Med. Tribune [online] 2015-06-30. Dostupný z: https://www.tribune.cz/clanek/36579-netuseny-vyznam-strevniho-mikrobialniho-ekosystemu
- Petanová J. Imunostimulační léčba v urologii. Urol. praxi, 2013; 14(3): 100-103. Dostupný z: https://www.urologiepropraxi.cz/pdfs/uro/2013/03/02.pdf
- Kranjčec B. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 2014, 32(1): 79-84. Dostupný z: https://www.ncbi.nlm.nih.gov/pubmed/23633128 Go to original source...
Go to PubMed... - Cervigni M. Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy. Transl Androl Urol, 2015 Dec; 4(6): 638-342. Dostupný z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708541/ Go to PubMed...
- Engelhardt PF. Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J., 2011; 22(4): 401-405. Dostupný z: https://www.ncbi.nlm.nih.gov/pubmed/20938644 Go to original source... Go to PubMed...
- Hanno PM. AUA guideline for the diagnosis and treatment of interstitial cystits/bladder pain syndrome. J Urol 2011 Jun; 185(6): 2162-2170. Dostupný z: https://www.ncbi.nlm.nih.gov/pubmed/21497847 Go to original source... Go to PubMed...
- Nosková P. Léčba bolesti u intersticiální cystitidy. Urol. praxi, 2008; 9(3): 112-115. Dostupný z: https://www.urologiepropraxi.cz/pdfs/uro/2008/03/03.pdf
- Conova S. Researchers Discover Cells that Restore Bladder's Unique Lining [online] 2013-09-19. Dostupný z: http://newsroom.cumc.columbia.edu/blog/2013/09/19/bladder-progenitors-discovered/ Go to original source...